1. Home
  2. DRUG
  3. DRUG News

Latest Bright Minds Biosciences Inc. (DRUG) News on November 22, 2024

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

GlobeNewswire

a month ago

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

Business Wire

5 months ago

Form 8.3 - Darktrace plc

Business Wire

5 months ago

Form 8.3 - DS Smith plc

Associated Press Finance

a year ago

Sonim: Q3 Earnings Snapshot

Thomson Reuters StreetEvents

a year ago

Q3 2023 Fossil Group Inc Earnings Call

Associated Press Finance

a year ago

Fossil Group: Q3 Earnings Snapshot

Share on Social Networks: